# apoQlar

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/apoqlar

- Industry: Healthcare IT
- Headquarters: Hamburg, Germany
- Website: www.apoqlar.com
- Total disclosed funding: $11M
- Latest round: Series A (May 5, 2024)
- Investors on record: 2

## About

Based in Hamburg, Germany, and founded in 2017, ApoQlar GmbH is a health technology company that focuses on developing a medical mixed reality platform to improve the overall healthcare experience for both practitioners and patients. The company was co-founded by Sirko Pelzl (CEO), Lukasz Radomski, and Marc-Angelo Bisotti. In May 2024, apoQlar GmbH raised EUR 10 million in series A funding from new investor IFB Innovationsstarter GmbH, with participation from returning investor YZR. Individual investors also participated in the round.

The company's software platform, VSI HoloMedicine, uses Microsoft HoloLens hardware to create an interactive 3D mixed-reality environment. This transformation of medical images, clinical workflows, and medical education improves patient outcomes and the clinical experience for physicians. 

The company plans to use the May 2024 funding to speed up its development and expansion.

## Funding rounds

- Series A, May 5, 2024, $11M — Innovationsstarter Fonds Hamburg, YZR

## Investors

- Innovationsstarter Fonds Hamburg (https://capitalatlas.ai/funds/innovationsstarter-fonds-hamburg) — Series A
- YZR (https://capitalatlas.ai/funds/yzr) — Series A